IEDS Trademark

Trademark Overview

On Wednesday, August 14, 2002, a trademark application was filed for IEDS with the United States Patent and Trademark Office. The USPTO has given the IEDS trademark a serial number of 78154179. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, May 27, 2008. This trademark is owned by Celltech Manufacturing, Inc.. The IEDS trademark is filed in the Pharmaceutical Products category with the following description:

Ion exchange resin coating for use as a drug delivery system, sold as a component of a pharmaceutical formulation comprising a drug-resin complex, which allows for controlled-release and delivery of pharmaceutical substances

General Information

Serial Number78154179
Word MarkIEDS
Filing DateWednesday, August 14, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, May 27, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 1, 2005

Trademark Statements

Goods and ServicesIon exchange resin coating for use as a drug delivery system, sold as a component of a pharmaceutical formulation comprising a drug-resin complex, which allows for controlled-release and delivery of pharmaceutical substances

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 10, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB MANUFACTURING, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressROCHESTER, NY 14623
Party NameCelltech Manufacturing, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRochester, NY 14623
Party NameCelltech Manufacturing, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRochester, NY 14623

Trademark Events

Event DateEvent Description
Wednesday, August 13, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, August 13, 2008ABANDONMENT - NO USE STATEMENT FILED
Friday, December 14, 2007EXTENSION 5 GRANTED
Saturday, November 24, 2007EXTENSION 5 FILED
Monday, November 26, 2007PAPER RECEIVED
Wednesday, November 21, 2007PAPER RECEIVED
Tuesday, July 17, 2007EXTENSION 4 GRANTED
Monday, March 26, 2007EXTENSION 4 FILED
Monday, March 26, 2007PAPER RECEIVED
Monday, March 26, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 22, 2006EXTENSION 3 GRANTED
Thursday, October 19, 2006EXTENSION 3 FILED
Thursday, October 19, 2006PAPER RECEIVED
Thursday, May 25, 2006EXTENSION 2 GRANTED
Tuesday, May 2, 2006EXTENSION 2 FILED
Tuesday, May 2, 2006PAPER RECEIVED
Tuesday, November 29, 2005EXTENSION 1 GRANTED
Monday, November 7, 2005EXTENSION 1 FILED
Monday, November 7, 2005PAPER RECEIVED
Tuesday, May 24, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2005PUBLISHED FOR OPPOSITION
Wednesday, February 9, 2005NOTICE OF PUBLICATION
Tuesday, December 28, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 9, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 4, 2004AMENDMENT FROM APPLICANT ENTERED
Monday, July 26, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 3, 2004ASSIGNED TO LIE
Monday, July 26, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 26, 2004FINAL REFUSAL MAILED
Wednesday, November 19, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 11, 2003CASE FILE IN TICRS
Wednesday, November 19, 2003TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 19, 2003NON-FINAL ACTION MAILED
Thursday, March 27, 2003ASSIGNED TO EXAMINER

Related Keywords

ieds delivery drug pharmaceutical resin allows which controlled release substances complex